Authors: BRANDES LJ BRACKEN SP

Citation: Lj. Brandes et Sp. Bracken, THE INTRACELLULAR HISTAMINE ANTAGONIST, DIETHYL-2-[4-(PHENYLMETHYL)PHENOXY]ETHANAMINE.HCL, MAY POTENTIATE DOXORUBICIN IN THE TREATMENT OF METASTATIC BREAST-CANCER - RESULTS OF A PILOT-STUDY, Breast cancer research and treatment, 49(1), 1998, pp. 61-68

Authors: BRANDES LJ BRACKEN SP RAMSEY EW

Citation: Lj. Brandes et al., N,N-DIETHYL-2-[4-(PHENYLMETHYL)PHENOXY]ETHANAMINE IN COMBINATION WITHCYCLOPHOSPHAMIDE - AN ACTIVE, LOW-TOXICITY REGIMEN FOR METASTATIC HORMONALLY UNRESPONSIVE PROSTATE-CANCER, Journal of clinical oncology, 13(6), 1995, pp. 1398-1403

Authors: BRANDES LJ SIMONS KJ BRACKEN SP WARRINGTON RC

Citation: Lj. Brandes et al., RESULTS OF A CLINICAL-TRIAL IN HUMANS WITH REFRACTORY CANCER OF THE INTRACELLULAR HISTAMINE ANTAGONIST, DIETHYL-2-[4-(PHENYLMETHYL)PHENOXY]ETHANAMINE-HCL, IN COMBINATION WITH VARIOUS SINGLE ANTINEOPLASTIC AGENTS, Journal of clinical oncology, 12(6), 1994, pp. 1281-1290